Lopardo G
Fundación Centro de Estudios Infectológicos (FUNCEI), Buenos Aires, Argentina.
Chemotherapy. 2001;47 Suppl 1:24-32. doi: 10.1159/000048565.
Patients with infective endocarditis often face lengthy hospitalization for parenteral antibiotic therapy. Efforts to reduce medical costs have led to consideration of outpatient parenteral antibiotic treatment (OPAT) for these patients. However, concerns about outpatient management of complications, particularly congestive heart failure and emboli, exist. In Argentina, carefully selected patients with infective endocarditis, representing a low-risk population, have been successfully treated with OPAT. A retrospective analysis was conducted of 48 such patients. Three delivery models were used: at home with medications given by the visiting nurse, at infusion center, or at home with medications self-administered. Ten patients received OPAT only; 38 were initially hospitalized, then transferred to an OPAT program. Twenty-nine patients had streptococcal disease, 37 out of 48 patients were treated with ceftriaxone. Clinical and microbiologic cure was achieved in all patients. Three patients developed heart failure, 2 prior to starting antibiotic therapy. Four developed emboli, all prior to starting antibiotics. Surgery was required in 5 patients: 2 were treated with OPAT postoperatively and 3 had surgery after antibiotic therapy was completed. OPAT for infective endocarditis is safe in well selected patients.
感染性心内膜炎患者通常需要长时间住院接受胃肠外抗生素治疗。降低医疗成本的努力促使人们考虑对这些患者进行门诊胃肠外抗生素治疗(OPAT)。然而,对于门诊并发症管理,尤其是充血性心力衰竭和栓塞,仍存在担忧。在阿根廷,经过精心挑选的感染性心内膜炎患者,属于低风险人群,已成功接受OPAT治疗。对48例此类患者进行了回顾性分析。采用了三种给药模式:在家由访视护士给药、在输液中心给药或在家自行给药。10例患者仅接受OPAT治疗;38例最初住院,然后转入OPAT项目。29例患者患有链球菌疾病,48例患者中有37例接受头孢曲松治疗。所有患者均实现临床和微生物学治愈。3例患者出现心力衰竭,2例在开始抗生素治疗前出现。4例发生栓塞,均在开始抗生素治疗前出现。5例患者需要手术:2例术后接受OPAT治疗,3例在抗生素治疗完成后进行手术。对于精心挑选的患者,感染性心内膜炎的OPAT治疗是安全的。